V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008048 | 190007411 | 1.71 | 70.6 | Curative (C) | null | 2021-05-07 | EW EuroEwing 2012 Arm A VAI | 02 | null | DOXORUBICIN + OLARATUMAB | 101836772 |
| 190008067 | 190007412 | 1.53 | 59.5 | Neo-adjuvant (N) | 2017-01-06 | 2017-12-07 | Carboplatin + Etoposide IV 3 day | 02 | null | NOT MATCHED | 100253779 |
| 190008079 | 190007413 | 1.71 | 77.3 | null | 2020-06-14 | 2020-06-14 | Carboplatin AUC 6 - 10 | null | null | CARBOPLATIN | 101186131 |
| 190008082 | 190007414 | 1.83 | 69.3 | Curative (C) | 2021-10-16 | 2022-01-13 | Carboplatin + Etoposide IV 3 day | 02 | N | DOXORUBICIN + OLARATUMAB | 101487489 |
| 190008135 | 190007415 | 1.72 | 54.6 | null | 2021-03-10 | 2021-03-10 | VAI (Ifos 3g/m2) | N | N | OCTREOTIDE | 100764551 |
| 190008148 | 190007416 | 1.75 | 77 | null | 2020-07-04 | 2020-07-08 | Cisplatin + Radiotherapy | 02 | Y | CISPLATIN | 100640897 |
| 190008170 | 190007417 | null | 79.4 | Curative (C) | 2017-12-19 | 2018-01-02 | Capecitabine | 02 | N | BEVACIZUMAB | 101093495 |
| 190008184 | 190007418 | 1.51 | 54 | null | 2016-08-21 | 2016-09-10 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE | 100306595 |
| 190008218 | 190007419 | 0 | 78 | Curative (C) | 2020-11-08 | 2021-05-27 | ETOPOSIDE | N | N | CAPECITABINE + CISPLATIN | 101377729 |
| 190008223 | 190007420 | 1.49 | 57.1 | Curative (C) | 2016-12-06 | 2016-12-27 | Cisplatin 7 day | 01 | N | CISPLATIN | 100530594 |
| 190008242 | 190007421 | 0 | 27.2 | null | 2018-04-15 | 2018-04-15 | NB HRNBL-1 Isotretinoin | 02 | N | TOPOTECAN | 101555265 |
| 190008264 | 190007422 | 1.6 | 38.3 | null | 2018-07-10 | 2018-08-03 | Dox + HD Mtx (post PAM) | null | null | OCTREOTIDE | 100399288 |
| 190008265 | 190007423 | 0 | 12.7 | null | 2018-10-01 | 2019-02-05 | VAI (Ifos 3g/m2) | 02 | N | TRIAL | 101201661 |
| 190008274 | 190007424 | 1.79 | null | Palliative (P) | 2019-03-29 | 2019-04-13 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | Y | CVD | 101354029 |
| 190008338 | 190007425 | 1.47 | 72.8 | Curative (C) | null | 2021-08-17 | Dox + HD Mtx (post PAM) | N | N | NIVOLUMAB | 100290628 |
| 190008339 | 190007426 | 1.7 | 89.4 | Palliative (P) | null | 2022-05-16 | Ifosfamide | null | null | ECX | 100681399 |
| 190008345 | 190007427 | 1.83 | 61.8 | null | null | 2022-05-28 | OST Euramos 1 Closed Trial - M | 02 | Y | CISPLATIN + GEMCITABINE | 101552853 |
| 190008359 | 190007428 | 0 | 12.7 | null | 2019-06-05 | 2019-06-27 | Trabectedin | 02 | null | CISPLATIN + GEMCITABINE | 101111083 |
| 190008369 | 190007429 | 1.52 | 63.4 | null | null | 2017-06-01 | null | 02 | null | LIPOSOMAL DOXORUBICIN | 100176079 |
| 190008373 | 190007430 | null | 62.9 | Adjuvant (A) | 2021-06-02 | 2021-06-24 | Capecitabine | 02 | null | CISPLATIN + GEMCITABINE | 100934867 |
| 190008417 | 190007432 | 1.62 | 76.6 | null | 2018-09-03 | 2018-09-03 | VAC | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100275307 |
| 190008428 | 190007433 | 1.81 | 47.8 | Palliative (P) | 2020-11-18 | 2020-12-22 | Dox + HD Mtx (post PAM) | 02 | N | CARBOPLATIN + ETOPOSIDE | 100505133 |
| 190008436 | 190007434 | null | 11.5 | Palliative (P) | 2019-04-19 | 2019-12-04 | null | 02 | N | GEMCITABINE | 100827736 |
| 190008474 | 190007435 | 1.78 | 63.15 | Curative (C) | 2019-11-12 | 2020-06-04 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101674078 |
| 190008489 | 190007436 | 1.64 | 161.4 | null | 2019-07-16 | 2019-08-02 | MAP + MIFAMURTIDE | 02 | N | CAPECITABINE + OXALIPLATIN | 100544585 |
| 190008490 | 190007437 | null | 57.4 | Palliative (P) | 2018-04-20 | 2018-08-21 | VAI (Ifos 3g/m2) | 02 | N | CAV | 100139618 |
| 190008496 | 190007438 | 1.62 | 48.4 | Neo-adjuvant (N) | null | 2020-09-02 | Rituximab | 02 | N | PACLITAXEL | 100687980 |
| 190008529 | 190007439 | 1.62 | null | Palliative (P) | null | 2018-08-02 | EW Rel Irinotecan & Temozolomide | null | null | CARBOPLATIN | 101165907 |
| 190008535 | 190007440 | 1.8 | 65.2 | Adjuvant (A) | 2020-01-02 | 2020-01-10 | null | 02 | N | CETUXIMAB | 100902655 |
| 190008538 | 190007441 | 1.71 | 94.85 | Neo-adjuvant (N) | 2019-05-31 | 2019-05-31 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | CAPECITABINE + OXALIPLATIN | 100795070 |
| 190008545 | 190007442 | null | 79 | Curative (C) | null | 2017-10-14 | EW EuroEwing 2012 Arm A VIDE | Y | N | SUNITINIB | 101346301 |
| 190008567 | 190007443 | 1.65 | 62.3 | Adjuvant (A) | null | 2018-12-12 | PAM x 2 pre-surgery (cycles 1&2) | null | null | EC | 100150432 |
| 190008572 | 190007444 | null | 59.55 | Adjuvant (A) | 2020-11-14 | 2020-11-17 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | CARBOPLATIN + FLUOROURACIL | 101317442 |
| 190008575 | 190007445 | 0 | 39.2 | Curative (C) | 2021-03-31 | 2021-04-16 | VAI (Ifos 3g/m2) | 02 | N | TRIAL UNSPECIFIED | 101320016 |
| 190008579 | 190007446 | 1.37 | 66.8 | Palliative (P) | 2022-04-29 | 2022-04-29 | EOX | 02 | N | CARBOPLATIN + GEMCITABINE | 101327356 |
| 190008626 | 190007447 | 1.74 | 38.7 | Adjuvant (A) | 2018-09-20 | 2018-10-25 | STS Rhabdomyosarcoma RMS 2005 IVA | 01 | N | NIVOLUMAB | 100506170 |
| 190008638 | 190007448 | 0 | 58.6 | Curative (C) | 2019-06-04 | 2019-06-18 | Cyclophosphamide + Vincristine | N | Y | CAPECITABINE + OXALIPLATIN | 101067062 |
| 190008647 | 190007449 | 1.28 | 25 | Curative (C) | 2013-05-26 | 2018-12-20 | Cisplatin+Gemcitabine (Days 1&8&15) | 01 | N | PACLITAXEL | 100996805 |
| 190008664 | 190007450 | 1.79 | 86 | Palliative (P) | 2022-05-10 | 2022-05-19 | OST Euramos 1 Closed Trial - M | N | N | CISPLATIN + GEMCITABINE + IFOSFAMIDE + PACLITAXEL | 101867880 |
| 190008671 | 190007451 | 1.57 | 56.1 | Palliative (P) | null | 2019-07-29 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101855085 |
| 190008763 | 190007452 | 0 | 36 | Adjuvant (A) | 2022-04-01 | 2022-04-11 | GemCarbo Days 1+8 | 02 | N | EVEROLIMUS | 101179629 |
| 190008779 | 190007453 | 1.7 | 32.6 | Curative (C) | 2019-07-03 | 2019-07-31 | Imatinib 200mg | 02 | null | CISPLATIN + FLUOROURACIL + RT | 100199904 |
| 190008789 | 190007454 | 1.87 | 88 | null | 2016-05-26 | 2016-06-04 | Cisplatin | null | null | CISPLATIN | 101074975 |
| 190008817 | 190007455 | 1.8 | 83 | Curative (C) | 2019-08-30 | 2019-12-31 | OST Euramos 1 Closed Trial - M | 02 | N | CARBOPLATIN + ETOPOSIDE | 101375934 |
| 190008819 | 190007456 | 1.52 | 18.8 | Curative (C) | 2021-07-28 | 2021-10-15 | OST Euramos 1 Closed Trial - M | 02 | N | CARBOPLATIN + DOCETAXEL | 100543326 |
| 190008845 | 190007457 | 0 | 11.6 | Palliative (P) | 2017-03-01 | 2017-06-24 | VAI (Ifos 3g/m2) | 02 | N | OCTREOTIDE | 100927741 |
| 190008855 | 190007458 | 1.8 | 149 | Adjuvant (A) | 2020-05-12 | 2020-12-23 | Oxaliplatin + Modified de Gramont | 02 | Y | CARBOPLATIN + PACLITAXEL | 101595057 |
| 190008866 | 190007459 | 1.82 | 89 | Curative (C) | 2019-09-13 | 2019-09-21 | NB HRNBL-1 COJEC Ind COURSE B | 02 | null | OXALIPLATIN + MDG | 101097471 |
| 190008891 | 190007460 | 0 | 36.2 | Palliative (P) | 2017-10-25 | 2017-10-31 | CARBOPLATIN + RT | 02 | N | CARBOPLATIN | 101394510 |
| 190008914 | 190007461 | 1.73 | 82 | null | 2020-10-20 | 2021-05-15 | Avelumab | 01 | null | RUCAPARIB | 100464288 |